Cogent Biosciences, Inc.
COGT NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 10, 2026
ET
EPS Est.
-0.56
EPS Actual
-0.52
Revenue Est.
$1000
Revenue Actual
--
Next Earnings Report Date unconfirmed
Date
Nov 6, 2026 · Fri
ET Nov 6, 2026 · Fri
Time
11/6 11:00-14:30
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
-0.57
Revenue Est.
$750000
Company Overview
Cogent Biosciences, Inc. (ticker COGT) is listed on NASDAQ with a market cap of about $5.3B. Its next earnings report (FY2026 Q3) is expected on Nov 6, 2026 (ET), Pre-market (date pending company confirmation), with consensus EPS of -0.57. In the last 15 reported quarters, EPS beat consensus estimates 5 times.
Actual EPS TrendRecently15Term · Mar 14, 2023 → Aug 10, 2026
Mar 14, 2023Range: -0.64 ~ -0.50Aug 10, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 10, 2026 | -- | -0.56 | Above forecast↑-0.52 | $1000 | -- |
| May 5, 2026 | -- | -0.53 | -0.53 | $500 | -- |
| Feb 17, 2026 | -- | -0.51 | Below forecast↓-0.55 | $1.7M | -- |
| Nov 7, 2025 | -- | -0.54 | Above forecast↑-0.50 | -- | -- |
| Aug 5, 2025 | -- | -0.55 | Above forecast↑-0.53 | -- | -- |
| May 6, 2025 | -- | -0.56 | Above forecast↑-0.52 | -- | -- |
| Feb 25, 2025 | -- | -0.59 | Below forecast↓-0.61 | -- | -- |
| Nov 12, 2024 | -- | -0.55 | Below forecast↓-0.64 | -- | -- |
| Aug 6, 2024 | -- | -0.55 | Below forecast↓-0.59 | -- | -- |
| May 7, 2024 | -- | -0.50 | Below forecast↓-0.62 | -- | -- |
| Feb 26, 2024 | -- | -0.54 | Below forecast↓-0.63 | -- | $5.6M |
| Nov 2, 2023 | -- | -0.50 | Below forecast↓-0.64 | -- | -- |
| Aug 8, 2023 | -- | -0.53 | Below forecast↓-0.59 | -- | -- |
| May 9, 2023 | -- | -0.58 | Above forecast↑-0.54 | -- | -- |
| Mar 14, 2023 | -- | -0.50 | Below forecast↓-0.56 | -- | -- |
Original Filings (SEC)
Quarterly10-Q · 2026-08-10 ↗
Earnings Release8-K · 2026-08-10 ↗
Quarterly10-Q · 2026-05-05 ↗
Earnings Release8-K · 2026-05-05 ↗
Annual10-K · 2026-02-17 ↗
Earnings Release8-K · 2026-02-17 ↗
Quarterly10-Q · 2025-11-07 ↗
Quarterly10-Q · 2025-08-05 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
